UBS ASSET MANAGEMENT AMERICAS LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 323 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 4.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,316,027
-34.6%
47,734
-14.1%
0.00%0.0%
Q2 2023$2,013,7360.0%55,5820.0%0.00%0.0%
Q1 2023$2,013,736
-1.2%
55,582
-2.7%
0.00%0.0%
Q4 2022$2,038,254
-99.9%
57,142
-2.6%
0.00%0.0%
Q3 2022$1,986,894,000
+30.6%
58,697
+11.5%
0.00%0.0%
Q2 2022$1,521,799,000
-12.1%
52,621
-1.8%
0.00%0.0%
Q1 2022$1,731,221,000
+35.0%
53,565
+21.8%
0.00%
Q4 2021$1,282,339,000
+6.2%
43,976
-2.9%
0.00%
-100.0%
Q3 2021$1,207,752,000
-13.4%
45,2850.0%0.00%0.0%
Q2 2021$1,394,324,000
+24.9%
45,285
+6.2%
0.00%
Q1 2021$1,116,054,000
+4.1%
42,6300.0%0.00%
-100.0%
Q4 2020$1,072,570,000
+20.7%
42,6300.0%0.00%
Q3 2020$888,410,000
-12.3%
42,6300.0%0.00%
-100.0%
Q2 2020$1,012,464,000
+81.6%
42,630
+37.6%
0.00%
Q1 2020$557,457,000
-42.8%
30,987
-24.6%
0.00%
-100.0%
Q4 2019$974,914,000
-25.6%
41,101
-13.8%
0.00%0.0%
Q3 2019$1,309,916,000
-1.2%
47,668
+19.0%
0.00%0.0%
Q2 2019$1,325,619,000
-77.8%
40,061
-76.5%
0.00%
-75.0%
Q1 2019$5,962,406,000
+6.9%
170,160
+1.3%
0.00%
-20.0%
Q4 2018$5,577,472,000
-37.5%
167,895
-5.2%
0.01%
-28.6%
Q3 2018$8,920,560,000
-12.0%
177,171
+4.6%
0.01%
-12.5%
Q2 2018$10,137,633,000
+21.9%
169,384
-6.7%
0.01%
+14.3%
Q1 2018$8,315,309,000
-13.4%
181,557
-24.7%
0.01%
-12.5%
Q4 2017$9,606,879,000
-2.6%
241,076
-2.2%
0.01%
-11.1%
Q3 2017$9,862,840,000
+14.5%
246,571
+23.4%
0.01%
+12.5%
Q2 2017$8,612,156,000
+1451.3%
199,818
+1026.6%
0.01%
+700.0%
Q1 2017$555,168,000
+219334.0%
17,737
+77.4%
0.00%
Q4 2016$253,000
-41.2%
10,000
-42.5%
0.00%
Q3 2016$430,000
+20.8%
17,400
-0.6%
0.00%
Q2 2016$356,000
+33.3%
17,5000.0%0.00%
Q1 2016$267,000
+4.7%
17,500
-7.9%
0.00%
Q4 2015$255,000
-4.5%
19,0000.0%0.00%
Q3 2015$267,000
-17.3%
19,0000.0%0.00%
Q2 2015$323,00019,0000.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders